CLINICAL_TRIALS
trial_result
· 2022-07-08
Clinical Trial Update: Tachosil for the Prevention of Symptomatic Lymph Cysts [Phase 3]
Summary
Phase 3 trial update on Tachosil for prevention of symptomatic lymph cysts in gynecologic cancer patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ruhr University of Bochum | Conditions: Endometrial Cancer, Cervical Cancer | Phase 3 | Status: COMPLETED